Brand Recall Hub
Affected Recalls in Canada
157 recalls found for Affected. Data sourced from Health Canada, CFIA, and Transport Canada. Updated daily.
157 Affected Recalls
Femyso: Affected lot may contain two green Mifepristone cartons or two pink Misoprostol cartons instead of one of each.
Packaging
View recall details →
PMS-FAMPRIDINE 10 mg Tablet: Affected lot may contain foreign material particles.
Contamination
View recall details →
IMAAVY: Affected lots may contain glass particles
Product quality
View recall details →
Platinum Naturals Easymulti Stress (men): Affected lots incorrectly labelled for Vitamin B6 quantity
Labelling
View recall details →
pms-IRBESARTAN: Affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.
Contamination
View recall details →
TEVA-ECTOSONE 0.1% Cream; Affected lot may be missing lot number and expiry date
Labelling
View recall details →
JAMP Methotrexate 10 mg Tablets: Affected lots may contain oversized tablets.
Product quality
View recall details →
Femyso: Affected lot may contain two green Mifepristone cartons or two pink Misoprostol cartons instead of one of each.
Packaging
View recall details →
Pharmasave Regular Strength Dairy Digestive Supplement Lactase Enzyme: Affected lot is labelled with the incorrect Natural Product Number (NPN) on the carton.
Labelling
View recall details →
ATTITUDE Bathroom Cleaner Disinfectant: Affected lot may be missing expiry date
Labelling
View recall details →
Hizentra: The appearance is out of specification in the affected lot.
Product quality
View recall details →
H2O: Presence of particulate matter in affected lot
Contamination
View recall details →
Max Slim Alpha-GPC + Citicoline: The affected lot contains an undeclared ingredient (caffeine)
Product quality
View recall details →
SUVEXX: The assay is out of specification in the affected lot.
Product quality
View recall details →
LUXA-D: A capsule containing a foreign product was found in the affected batch.
Product safety
View recall details →
Auro-Canagliflozin: Affected lots are labelled with the incorrect DIN found on the blister card.
Product safety
View recall details →
HIZENTRA: The appearance is out of specification in the affected lot.
Product safety
View recall details →
Disinfectant Spray & Wipe Cleaner: Affected lots contain solution that do not meet the labelled strength
Product safety
View recall details →
KETOROLAC: The weight is out of specification in the affected lots.
Product quality
View recall details →
APO-BRIMONIDINE-TIMOP: The weight is out of specification in the affected lot.
Product safety
View recall details →
Champignons et Adaptogènes: Affected lot contains concentrations for certain ingredients that differ from the concentration on the label.
Dosage
View recall details →
CEFAZOLIN FOR INJECTION : Vials may be underfilled in the affected lot.
Product quality
View recall details →
APO-CANDESARTAN: Affected lots were manufactured using an active ingredient that was out of specification for dissolution
Product quality
View recall details →
Seasonique, Seasonale tablets: Affected lot(s) may not contain the correct amount of tablets (missing blister card)
Product quality
View recall details →
MAR-AMLODIPINE: affected lots may contain tablet(s) of Midodrine 2.5mg tablets.
Product safety
View recall details →
Cefazolin for Injection: Affected lots are packaged with the incorrect Linear barcode on inner and outer bag labels.
Labelling
View recall details →
TARO-CANDESARTAN: Affected lots were manufactured using an active ingredient that was out of specification for dissolution
Product quality
View recall details →
Viazen Immunity: The selenium content is out of specification in the affected batch.
Product quality
View recall details →
Teva-Topilene Ointment 0.05%: The assay is potentially out of specification in the affected lot during its shelf life.
Product quality
View recall details →
Sure Hoof: Affected lot is missing some ingredients on the label
Product safety
View recall details →
Showing 30 of 157 recalls. View all →